Advances in vascular brachytherapy over the last 10 years: Focus on femoropopliteal applications

Journal of Endovascular Therapy

Volumn 11, Issue SUPPL. 2, 2004, Pages

  Schillinger, Martin ^a   Minar, Erich ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Balloon angioplasty; Beta irradiation; Brachytherapy; Complications; Gamma radiation; Restenosis; Stent

Indexed keywords

ANEURYSM; BRACHYTHERAPY; CATHETERIZATION; FEMORAL ARTERY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RESTENOSIS; REVIEW; STENT; TECHNOLOGY; THROMBOSIS;

EID: 12144249439     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1177/15266028040110s619     Document Type: Review

References (47)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
2. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 1991;83(2suppl):I70-I80.
3. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767-771.
4. Wolf GL, Wilson SE, Cross AP, et al. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal Investigators and Their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol. 1993;4:639-648.
5. Whyman MR, Fowkes FG, Kerracher EM, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg. 1997;26:551-557.
6. Treiman GS, Ichikawa L, Treiman RL, et al. Treatment of recurrent femoral or popliteal artery stenosis after percutaneous transluminal angioplasty. J Vasc Surg. 1994;20:577-587.
7. Schillinger M, Mlekusch W, Haumer M, et al. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther. 2003;10:288-297.
8. Cejna M, Thurnher SA, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
9. Grimm J, Muller-Hulsbeck S, Jahnke T, et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12:935-942.
10. Muradin GS, Bosch JL, Stijnen T, et al. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology. 2001;221:137-145.
11. Vroegindeweij D, Vos LD, Tielbeek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425.
12. Sabeti S, Schillinger M, Amighi J, et al. Patency of nitinol vs. Wallstents in the superficial femoral artery - a propensity score adjusted analysis. Radiology. 2004;232:516-521.
13. Minar E. Medikamentöse Rezidivprophylaxe. In: Vallbracht C, Roth FJ, Strauss AL, eds. Interventionelle Gefäßtherapie. Darmstadt: Steinkopff Verlag; 2002.
14. Duda SH, Pusich B, Richter G, et al. Sirolimuseluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505-1509.
15. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:1697-1703.
16. Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with instent restenosis. Circulation. 2000;101:2165-2171.
17. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001;344:250-256.
18. Waksman R, Bhargava B, White L, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation. 2000;101:1895-1898.
19. Kleiman NS, Califf RM. Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. J Am Coll Cardiol. 2000;36:310-325.
20. Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomized controlled trial. Lancet. 2002;359:551-557.
21. Hall EJ, Miller RC, Brenner DJ. Radiobiological principles in intravascular irradiation. Cardiovasc Radit Med. 1999;1:42-47.
22. Schwartz SM, Reidy MA. Restenosis: an assessment of factors important in arterial occlusion. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven; 1996:701-714.
23. Scott NA, Cipolla GD, Ross CE, et al. Identification of a potential role of the adventitia in vascular lesion formation after balloon over-stretch injury of porcine coronary arteries. Circulation. 1996;93:2178-2187.
24. Christen T, Verin V, Bochaton-Piallat M, et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation. 2001;103:882-888.
25. Pötter R, van Limbergen E, Dries W, et al. Prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. EndoVAscular GEC ESTRO Working Group (EVA GEC ESTRO). Radiother Oncol. 2001;59:339-360.
26. Kaluza GL, Mazur W, Raizner AE. Basic science review: radiotherapy for prevention of restenosis. Catheter Cardiovasc Interv. 2001;103:518-529.
27. Coussement PK, de Leon H, Ueno T, et al. Intracoronary beta radiation exacerbates long-term neointima formation in balloon-injured pig coronary arteries. Circulation. 2001;104:2459-2464.
28. Kaluza GL, Raizner AE, Mazur W, et al. Long-term effects of intracoronary beta-radiation in balloon- and stent-injured porcine coronary arteries. Circulation. 2001;103:2108-2113.
29. Nori D. Cardiovascular Radiation Therapy IV: Principles of External Radiation for Vascular Applications. Syllabus. Washington, DC; 2000: 204.
30. Steidle B. Preventive percutaneous radiation therapy to avoid hyperplasia of the intima after angioplasty combined with stent-implantation [in German]. Strahlenther Onkol. 1994;170:151-154.
31. nd ESTRO Meeting on Radiotherapy for Non-Malignant Diseases, France, Nice, 1-3 April 2004. [Abstract]. Radiother Oncol. 2004;71:S20.
32. Fritz P, Stein U, Hasslacher C, et al. External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: results of a prospective randomized double-blind study. Int J Radiat Oncol Biol Phy. 2004;59:815-821.
33. Bottcher HD, Schopohl B, Liermann D, et al. Endovascular irradiation: a new method to avoid recurrent stenosis after stent implantation in peripheral arteries-technique and preliminary results. Int J Radiat Oncol Biol Phys. 1994;29:183-186.
34. Liermann DD, Bauernsachs R, Schopohl B, et al. Intravascular irradiation therapy. In: Waksman R, ed. Vascular Brachytherapy. 2nd ed. Armonk, NY: Futura Publishing; 1999:395-405.
35. Zehnder T, von Briel C, Baumgartner I, et al. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions. J Endovasc Ther. 2003;10:304-311.
36. Gallino A, Do DD, Alerci M. et al. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. J Endovasc Ther. 2004;11:595-604.
37. Bonvini R, Baumgartner I, Do DD, et al. Late thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. J Am Coll Cardiol. 2003;41:409-412.
38. Waksman R, Laird JR, Jurkovitz CT, et al. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol. 2001;12:915-921.
39. Krueger K, Zaehringer M, Bendel M, et al. De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty-angiographic and clinical follow-up in a prospective randomized controlled trial. Radiology. 2004;231:546-554.
40. Minar E, Pokrajac B, Ahmadi R, et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology. 1998;208:173-179.
41. Minar E, Pokrajac B, Maca T, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation. 2000;102:2694-2699.
42. Waksman R. Intracoronary radiation therapy for restenosis prevention: status of the clinical trials. Cardiovasc Radiat Med. 1999;1:20-29.
43. Jani SK. Gamma vs beta irradiation: which is superior? Cardiovasc Radiat Med. 1999;1:102-106.
44. Pokrajac B, Schmid R, Pötter R, et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study [Abstract]. Int J Radiat Oncol Biol Phys. 2003;57(2 Suppl):S250.
45. Wolfram RM, Pokrajac B, Ahmadi R, et al. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology. 2001;220:724-729.
46. Costa MA, Sabaté M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation. 1999;100:789-792.
47. 192Iridium after femoropopliteal stenting in high risk patients-results from the Vienna-5 trial [Abstract]. J Kardiol. 2003;10(Suppl H):19.